Promega Enters Genotyping Market with ReadIt System | GenomeWeb

NEW YORK, May 23 – Promega marked its entry into the genotyping market Wednesday, announcing that it would make its ReadIt system commercially available to select laboratories.

“We are now launching a controlled sales program where we carefully identify our prospect and offer a lot of support and help,” said Richard Schifreen, business unit leader for Promega’s molecular diagnostics business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.